Latest
Locals Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Business Brii Biosciences LimitedAugust 20, 2026 Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026Emerging Discovery Programs Build MomentumBRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCCStrong Cash Position Supports Continued...
